Alexa Fluor® 647 anti-mouse CD206 (MMR) Antibo
- 产品名称：
- Alexa Fluor® 647 anti-mouse CD206 (MMR) Antibo
- 产品类别：
- 抗体
- 产品编号：
- 141711
- 产品应用：
- 141711
- Verified Reactivity
- Mouse
- Antibody Type
- Monoclonal
- Host Species
- Rat
- Immunogen
- Recombinant mouse CD206 (MMR)
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
- Preparation
- The antibody was purified by affinity chromatography and conjugated with Alexa Fluor? 647 under optimal conditions.
- Concentration
- 0.5 mg/mL
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
ICFC - Quality tested
FC, IHC-F - Verified
- Recommended Usage
Each lot of this antibody is quality control tested by intracellular immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.5 ?g per million cells in 100 ?L?volume. For immunohistochemistry on frozen tissue sections, a concentration range of 2.5 - 5.0 ?g/mL?is suggested. It is recommended that the reagent be titrated for optimal performance for each application.
* Alexa Fluor? 647 has a maximum emission of 668 nm when it is excited at 633 nm / 635 nm.
Alexa Fluor? and Pacific Blue? are trademarks of Life Technologies Corporation.
View full statement regarding label licenses - Excitation Laser
- Red Laser (633 nm)
- Application Notes
Clone C068C2 recognizes a region similar to clone MR5D3, based on the ability of the clones to block each other. Additional reported applications (for the relevant formats) include: spatial biology (IBEX)4,5.
- Application References
(PubMed link indicates BioLegend citation) -
- Keller J, et al. 2012. Biochem Biophys Res Commun. 417:217. PubMed
- Ito H, et al. 2012. J Am Soc Nephrol. 23:1797. PubMed
- Yang X, et al. 2015. PNAS. 112:2900. PubMed
- Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
- Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
- Product Citations
-
- Kretschmer I, et al. 2016. J Biol Chem. 291: 4091 - 4106. PubMed
- Barkaway A, et al. 2021. Immunity. . PubMed
- Chandran S, et al. 2020. Front Immunol. 11:787. PubMed
- Song Y, et al. 2013. Eur J Pharmacol. 705:49. PubMed
- Huang Z et al. 2017. Cell metabolism. 26(3):493-508 . PubMed
- Kim YS, et al. 2021. Cell Death Dis. 12:307. PubMed
- Hu HJ, et al. 2020. Cell Death Dis. 1.168055556. PubMed
- Tang E, et al. 2015. J Lipid Res. 56:358. PubMed
- Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
- Rybalko V, et al. 2015. PLoS One. 10: 0145550. PubMed
- Helsley RN, et al. 2020. eLife. 8:e49882.. PubMed
- Howell KL, et al. 2021. FASEB J. 35:e21618. PubMed
- Chen L, et al. 2020. J Exp Med. 217:00:00. PubMed
- Calvo-Barreiro L, et al. 2021. Neurotherapeutics. . PubMed
- Brykczynska U, et al. 2020. Cell Reports. 30(5):1627-1643.e7.. PubMed
- Sato H, et al. 2020. Cell Reports. 31(5):107579. PubMed
- Xu Z, et al. 2022. Int J Mol Sci. 23:. PubMed
- Mao FY, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:395. PubMed
- Guo P, et al. 2021. J Immunol. 207:408. PubMed
- Keller J, et al. 2012. Biochem Biophys Res Commun. 417:217. PubMed
- Enam SF, et al. 2020. J Neuroinflammation. 0.845138889. PubMed
- Kumaran Satyanarayanan S, et al. 2019. Nat Commun. 10:3471. PubMed
- Lee DY, et al. 2020. Chonnam Med J. 56:12:00. PubMed
- Zhang C, et al. 2022. Nat Commun. 13:3468. PubMed
- Herrada AA, et al. 2022. Front Immunol. 13:841641. PubMed
- De Simone G, et al. 2021. Immunity. :. PubMed
- Garre JM, et al. 2020. Nat Commun. 11:1784. PubMed
- Li H, et al. 2022. Gut Microbes. 14:2127456. PubMed
- Blriot C, et al. 2021. Immunity. :. PubMed
- Ren Y, et al. 2020. Stem Cell Res Ther. 0.743055556. PubMed
- Wang H, et al. 2016. PLoS One. 11:e0167307. PubMed
- Yu H, et al. 2021. Front Oncol. 11:736882. PubMed
- Carestia A, et al. 2019. Cell Rep. 28:896. PubMed
- Mohammadi MR, et al. 2021. Commun Biol. 4:685. PubMed
- Hightower RM, et al. 2019. Mol Ther. 28:189. PubMed
- Cianciaruso C, et al. 2020. Cell Reports. 27(10):3062-3080.e11.. PubMed
- He S, et al. 2021. Front Pharmacol. 12:743837. PubMed
- Zhu Q, et al. 2022. Atherosclerosis. 357:41. PubMed
- Ito H, et al. 2012. J Am Soc Nephrol. 23:1797. PubMed
- Roux C, et al. 2021. Antioxidants (Basel). 10:. PubMed
- Gao L, et al. 2021. Exp Ther Med. 22:1367. PubMed
- Put S, et al. 2013. J Nucl Med. 54:807. PubMed
- Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed
- Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
- Budhu S, et al. 2021. Cell Reports. 34(2):108620. PubMed
- Silva HM, et al. 2019. J Exp Med. 216:786. PubMed
- Eixarch H, et al. 2020. Neurotherapeutics. 17:1988. PubMed
- De Micheli AJ, et al. 2020. Am J Physiol Cell Physiol. 319:C885. PubMed
- Li H, et al. 2018. Nat Commun. 9:272. PubMed
- Wang L, et al. 2020. J Nanobiotechnology. 18:38. PubMed
- Scheyltjens I, et al. 2022. Nat Protoc. 17:2354. PubMed
- Chakraborty A, et al. 2021. Biomaterials. 273:120796. PubMed
- RRID
- AB_10900240 (BioLegend Cat. No. 141711) AB_10900420 (BioLegend Cat. No. 141712)
- Structure
- Type I transmembrane protein, 175 kD, C-type lectin superfamily
- Distribution
-
Macrophages, dendritic cells, Langerhans cells, liver endothelial cells
- Function
- Pathogen recognition, endocytosis and phagocytosis, antigen presentation
- Ligand/Receptor
- Antigen containing mannose, fucose, or an N-acetyl glucosamine
- Cell Type
- Dendritic cells, Endothelial cells, Langerhans cells, Macrophages
- Biology Area
- Cell Biology, Immunology, Innate Immunity, Signal Transduction
- Molecular Family
- CD Molecules
- Antigen References
-
1. Wileman TE, et al. 1986. P. Natl. Acad. Sci. USA 83:2501.
2. Apostolopoulos V, et al. 2001. Curr. Mol. Med. 1:469.
3. Burgdorf S, et al. 2006. J. Immunol. 176:6770.
4. McKenzie EJ, et al. 2007. J. Immunol. 178:4975.
- Gene ID
- 17533 View all products for this Gene ID
- UniProt
- View information about CD206 on UniProt.org
